PRF1 and X-linked lymphoproliferative disease: Moreover, so-called T-cell gene therapy is being studied for the correction of T cell–intrinsic defects with encouraging results, and trials are under way for IPEX, hyper IgM syndrome, X-linked lymphoproliferative disease, Munc 13-4 deficiency, and perforin deficiency207,212–216.